Antithrombin therapy to support PCI: Revision history

5 September 2022

• curprev 03:0803:08, 5 September 2022‎ Anahita talk contribs‎ 82,990 bytes +938‎ No edit summary
• curprev 03:0703:07, 5 September 2022‎ Anahita talk contribs‎ 82,052 bytes −1‎ No edit summary

6 August 2022

• curprev 14:3414:34, 6 August 2022‎ Anahita talk contribs‎ 82,053 bytes +1,440‎ →‎Enoxaparin

5 August 2022

• curprev 08:3008:30, 5 August 2022‎ Anahita talk contribs‎ 80,613 bytes +1,258‎ →‎Enoxaparin
• curprev 08:2608:26, 5 August 2022‎ Anahita talk contribs‎ 79,355 bytes −2‎ →‎Clinical Trials with Enoxaparin
• curprev 08:2608:26, 5 August 2022‎ Anahita talk contribs‎ 79,357 bytes −1‎ →‎Clinical Trials with Enoxaparin
• curprev 08:2508:25, 5 August 2022‎ Anahita talk contribs‎ 79,358 bytes +1,535‎ →‎Clinical Trials with Enoxaparin

4 August 2022

• curprev 09:4309:43, 4 August 2022‎ Anahita talk contribs‎ 77,823 bytes +3,741‎ →‎Low Molecular Weight Heparinoids (LMWH)
• curprev 09:3209:32, 4 August 2022‎ Anahita talk contribs‎ 74,082 bytes +387‎ →‎Direct thrombin inhibitor
• curprev 09:2909:29, 4 August 2022‎ Anahita talk contribs‎ 73,695 bytes +325‎ →‎Low Molecular Weight Heparinoids (LMWH)
• curprev 09:2409:24, 4 August 2022‎ Anahita talk contribs‎ 73,370 bytes +141‎ →‎Mechanism of Action
• curprev 09:1809:18, 4 August 2022‎ Anahita talk contribs‎ 73,229 bytes +1‎ →‎Advantages
• curprev 09:1609:16, 4 August 2022‎ Anahita talk contribs‎ 73,228 bytes +776‎ →‎Trials with Bivalirudin

1 August 2022

• curprev 19:1319:13, 1 August 2022‎ Anahita talk contribs‎ 72,452 bytes +1,394‎ →‎Trials with Bivalirudin
• curprev 19:0619:06, 1 August 2022‎ Anahita talk contribs‎ 71,058 bytes +8,133‎ →‎Trials with Bivalirudin
• curprev 18:5418:54, 1 August 2022‎ Anahita talk contribs‎ 62,925 bytes +47‎ →‎Disadvantages
• curprev 18:5218:52, 1 August 2022‎ Anahita talk contribs‎ 62,878 bytes +1,298‎ →‎Low Molecular Weight Heparinoids (LMWH)
• curprev 18:4818:48, 1 August 2022‎ Anahita talk contribs‎ 61,580 bytes +3,966‎ →‎Unfractionated Heparin (UFH)

31 July 2022

• curprev 07:2407:24, 31 July 2022‎ Anahita talk contribs‎ 57,614 bytes −1‎ →‎Antithrombin Therapy to Support PCI
• curprev 07:2407:24, 31 July 2022‎ Anahita talk contribs‎ 57,615 bytes +3,926‎ →‎Antithrombin Therapy to Support PCI

30 July 2022

• curprev 20:1020:10, 30 July 2022‎ Anahita talk contribs‎ 53,689 bytes +1,802‎ →‎Antithrombin Therapy to Support PCI
• curprev 20:0720:07, 30 July 2022‎ Anahita talk contribs‎ 51,887 bytes +323‎ →‎Antithrombin Therapy to Support PCI
• curprev 20:0620:06, 30 July 2022‎ Anahita talk contribs‎ 51,564 bytes +108‎ →‎Antithrombin Therapy to Support PCI
• curprev 20:0320:03, 30 July 2022‎ Anahita talk contribs‎ 51,456 bytes −28‎ →‎Antithrombin Therapy to Support PCI
• curprev 20:0320:03, 30 July 2022‎ Anahita talk contribs‎ 51,484 bytes +1,809‎ →‎Antithrombin Therapy to Support PCI

27 July 2022

• curprev 21:2421:24, 27 July 2022‎ Anahita talk contribs‎ 49,675 bytes +19‎ No edit summary
• curprev 21:2121:21, 27 July 2022‎ Anahita talk contribs‎ 49,656 bytes +898‎ →‎Antithrombin Therapy to Support PCI
• curprev 21:1621:16, 27 July 2022‎ Anahita talk contribs‎ 48,758 bytes +1,738‎ →‎Antithrombin Therapy to Support PCI
• curprev 21:0921:09, 27 July 2022‎ Anahita talk contribs‎ 47,020 bytes +854‎ →‎Antithrombin Therapy to Support PCI
• curprev 21:0621:06, 27 July 2022‎ Anahita talk contribs‎ 46,166 bytes +2,006‎ →‎2021 ACA Revascularization Guideline
• curprev 21:0221:02, 27 July 2022‎ Anahita talk contribs‎ 44,160 bytes +2,620‎ →‎2021 ACA Revascularization Guideline
• curprev 20:5120:51, 27 July 2022‎ Anahita talk contribs‎ 41,540 bytes +11,637‎ No edit summary

14 March 2016

• curprev 21:5021:50, 14 March 2016‎ WikiBot talk contribs‎ m 29,903 bytes +30‎ Bot: Adding CME Category::Cardiology

22 January 2013

• curprev 18:5618:56, 22 January 2013‎ Shankar Kumar talk contribs‎ m 29,873 bytes 0‎ Shankar Kumar moved page Antithrombin Therapy to Support PCI (patient information) to Antithrombin therapy to support PCI
• curprev 18:5618:56, 22 January 2013‎ Shankar Kumar talk contribs‎ 29,873 bytes −38‎ No edit summary

9 January 2013

• curprev 14:0014:00, 9 January 2013‎ Shankar Kumar talk contribs‎ 29,911 bytes +2‎ /* Bivalirudin and Argatoban (DO NOT EDIT){{cite journal|author=Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nall...

4 January 2013

• curprev 21:4921:49, 4 January 2013‎ Shankar Kumar talk contribs‎ 29,909 bytes +1‎ /* Enoxaparin (DO NOT EDIT){{cite journal |author=Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamothu BK, Tin...
• curprev 21:4421:44, 4 January 2013‎ Shankar Kumar talk contribs‎ 29,908 bytes +5‎ /* Unfractionated Heparin (DO NOT EDIT){{cite journal|author=Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri L, Mehran R, Moussa ID, Mukherjee D, Nallamo...
• curprev 21:3821:38, 4 January 2013‎ Shankar Kumar talk contribs‎ 29,903 bytes +1‎ →‎Trials with Bivalirudin
• curprev 21:3721:37, 4 January 2013‎ Shankar Kumar talk contribs‎ 29,902 bytes 0‎ →‎Trials with Bivalirudin
• curprev 21:3221:32, 4 January 2013‎ Shankar Kumar talk contribs‎ 29,902 bytes +368‎ →‎Trials with Bivalirudin
• curprev 21:0921:09, 4 January 2013‎ Shankar Kumar talk contribs‎ 29,534 bytes +27‎ →‎Disadvantages
• curprev 20:4020:40, 4 January 2013‎ Shankar Kumar talk contribs‎ 29,507 bytes +32‎ →‎Advantages
• curprev 20:3720:37, 4 January 2013‎ Shankar Kumar talk contribs‎ 29,475 bytes +150‎ →‎Mechanism of Action
• curprev 20:2220:22, 4 January 2013‎ Shankar Kumar talk contribs‎ 29,325 bytes +20‎ →‎Disadvantages
• curprev 20:2020:20, 4 January 2013‎ Shankar Kumar talk contribs‎ 29,305 bytes +161‎ →‎Advantages
• curprev 20:0920:09, 4 January 2013‎ Shankar Kumar talk contribs‎ 29,144 bytes +12‎ →‎Advantages
• curprev 20:0520:05, 4 January 2013‎ Shankar Kumar talk contribs‎ 29,132 bytes 0‎ →‎Mechanism of action
• curprev 20:0520:05, 4 January 2013‎ Shankar Kumar talk contribs‎ 29,132 bytes 0‎ →‎Mechanism of action
• curprev 20:0420:04, 4 January 2013‎ Shankar Kumar talk contribs‎ 29,132 bytes +102‎ →‎Unfractionated Heparin (UFH)
• curprev 19:2719:27, 4 January 2013‎ Shankar Kumar talk contribs‎ 29,030 bytes +28‎ No edit summary
• curprev 19:2319:23, 4 January 2013‎ Shankar Kumar talk contribs‎ 29,002 bytes +141‎ No edit summary

5 November 2012

• curprev 16:2416:24, 5 November 2012‎ Kalsang Dolma talk contribs‎ 28,861 bytes −2,268‎ No edit summary

19 October 2012

• curprev 13:5313:53, 19 October 2012‎ Shankar Kumar talk contribs‎ 31,129 bytes +2‎ /* ACCF/AHA/SCAI 2011 Guideline for Percutaneous Coronary Intervention: Bivalirudin and Argatoban{{cite journal |author=Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, L...
• curprev 13:4913:49, 19 October 2012‎ Shankar Kumar talk contribs‎ 31,127 bytes +2‎ /* ACCF/AHA/SCAI 2011 Guideline for Percutaneous Coronary Intervention: Fondaparinux{{cite journal |author=Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Maur...
• curprev 13:4613:46, 19 October 2012‎ Shankar Kumar talk contribs‎ 31,125 bytes +4‎ /* ACCF/AHA/SCAI 2011 Guideline for Percutaneous Coronary Intervention: Enoxaparin{{cite journal |author=Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lange RA, Mauri ...
• curprev 13:4313:43, 19 October 2012‎ Shankar Kumar talk contribs‎ 31,121 bytes +1‎ /* ACCF/AHA/SCAI 2011 Guideline for Percutaneous Coronary Intervention: Unfractionated Heparin {{cite journal |author=Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenberg SM, Khot UN, Lan...
• curprev 13:4113:41, 19 October 2012‎ Shankar Kumar talk contribs‎ 31,120 bytes +1‎ /* ACCF/AHA/SCAI 2011 Guideline for Percutaneous Coronary Intervention: Use of Parenteral Anticoagulants during PCI{{cite journal |author=Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA, Hollenb...

11 October 2012

• curprev 15:0815:08, 11 October 2012‎ Shankar Kumar talk contribs‎ 31,119 bytes −1,015‎ No edit summary

10 October 2012

• curprev 15:0015:00, 10 October 2012‎ Shankar Kumar talk contribs‎ 32,134 bytes +1,409‎ No edit summary
• curprev 14:5214:52, 10 October 2012‎ Shankar Kumar talk contribs‎ 30,725 bytes +24,008‎ No edit summary

8 August 2012

• curprev 22:2122:21, 8 August 2012‎ WikiBot talk contribs‎ m 6,717 bytes +6,717‎ Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)